Steve Tutewohl compensation by year
Evolent Health Summary Compensation Table · all 4 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Salary | $375,000 | $375,000 | $395,833 | $233,333 |
| Bonus | $702,750 | $702,750 | $255,200 | $232,329 |
| Stock awards | $363,600 | $874,385 | $1,096,000 | $1,472,316 |
| Option awards | $0 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $11,400 | $11,600 | $12,200 | $436,040 |
| Total | $1,452,750 | $1,963,735 | $1,759,233 | $2,374,018 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evolent Health, Inc. DEF 14A filed April 26, 2024, accession 0001193125-24-118116, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Evolent Health, Inc. filed document, accession 0001193125-24-118116. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 17,205 | $568,297 | — |
| PSU | 8,964 | $296,074 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Evolent Health, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2023 proxy (filed April 26, 2024)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2023-07-01 | Grant or award | — | 9,000 | $0.00 | 136,331 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Evolent Health’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Seth Blackley | Chief Executive Officer (3) | $8,931,188 |
| Daniel McCarthy | President (4) | $5,763,625 |
| John Johnson | Chief Financial Officer | $3,530,596 |
| Steve Tutewohl · this page | Former Chief Operating Officer | $2,374,018 |
| Emily Rafferty | Chief Operating Officer (4) | $2,291,560 |
| Jonathan Weinberg | General Counsel (5) | $2,012,894 |
The full Evolent Health compensation record
free company briefThis page is one person within Evolent Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Evolent Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Evolent Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.